Personalized ddPCR Monitoring Enables Prompt Leukemia Treatment Decisions
Personalized ddPCR monitoring of rare genetic alterations can help clinicians make timely treatment decisions for patients with leukemia, according to research.
Read More
Ad Code: Doptelet - Hematology - JUL Display Banners HCP Wallboard Extension - 104884
Critical Illness Linked to Increased VTE Risk
In patients with blood cancer, critical illness and baseline characteristics were associated with an increased risk of venous thromboembolism (VTE), according to research in Intensive Care Medicine. Federico C. Carini, MD, and...
Read More
Persistent Sociodemographic Differences Seen in Use of AutoHCT for Multiple Myeloma
WEDNESDAY, May 8, 2024 (HealthDay News) — Sociodemographic differences persist in...
Read MoreComplete Response Rate Important Surrogate Endpoint in CLL/SLL
Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/ SLL) is the most common leukemia in adults. Patients with relapsed/refractory (R/R) CLL/SLL who reach complete remission (CR) usually have slower disease progression...
Read MoreInfectious Diseases Raise Mortality in Multiple Myeloma
A heightened state of immunosuppression renders patients with MM particularly susceptible to infections. For a study presented at the 2024 ASCO Annual Meeting, investigators examined the changes in mortality rates due to...
Read More